Xylem Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xylem Inc. on March 27, 2019. The report discloses a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a new director and does not contain financial performance data.
Material Changes
On March 27, 2019, the Board of Directors elected Jorge M. Gomez as a director, effective immediately. Mr. Gomez currently serves as the Chief Financial Officer of Cardinal Health, Inc. His committee assignments will be determined at the next regularly scheduled Board meeting.
Guidance, Outlook, and Management Commentary
Mr. Gomez's compensation will align with the standard compensatory arrangement for non-employee directors as outlined in the Company's proxy statement filed on March 28, 2018. His cash retainer for the current term will be prorated. The filing confirms there are no undisclosed arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the effective date of Jorge M. Gomez's directorship (March 27, 2019).
- Review the Company's most recent proxy statement (filed March 28, 2018) for details on standard non-employee director compensation.
- Monitor upcoming Board meeting minutes for Mr. Gomez's specific committee appointments.
- Confirm the absence of any undisclosed transactions between Mr. Gomez and the Company.